List of SBIR/STTR awards granted to BridgeSource Medical, Corp.
BridgeSource Medical, Corp.Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to BridgeSource Medical, Corp. in July, 2021 for $256,458.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44EB030973-01A1 | Phase I | 256,458 | July 1, 2021 | |||||||
A SBIR Phase II contract was awarded to BridgeSource Medical, Corp. in September, 2022 for $740,251.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44EB030973-02 | Phase II | 740,251 | September 30, 2022 | |||||||
A SBIR Phase I contract was awarded to BridgeSource Medical, Corp. in September, 2021 for $299,880.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AG074121-01 | Phase I | 299,880 | September 30, 2021 | |||||||
A SBIR Phase I contract was awarded to BridgeSource Medical, Corp. in May, 2019 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL145847-01A1 | Phase I | 225,000 | May 3, 2019 | |||||||
A SBIR Phase II contract was awarded to BridgeSource Medical, Corp. in August, 2019 for $670,078.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AG059499-02 | Phase II | 670,078 | August 1, 2019 | |||||||
A SBIR Phase I contract was awarded to BridgeSource Medical, Corp. in May, 2018 for $224,954.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AG059499-01 | Phase I | 224,954 | May 1, 2018 | |||||||
A SBIR Phase II contract was awarded to BridgeSource Medical, Corp. in June, 2022 for $498,595.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44HL145847-02A1 | Phase II | 498,595 | June 15, 2022 | |||||||
A SBIR Phase I contract was awarded to BridgeSource Medical, Corp. in August, 2020 for $251,797.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL154960-01 | Phase I | 251,797 | August 1, 2020 | |||||||
A SBIR Phase II contract was awarded to BridgeSource Medical, Corp. in August, 2022 for $979,528.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44AG074121-02 | Phase II | 979,528 | August 2, 2022 | |||||||
A SBIR Phase II contract was awarded to BridgeSource Medical, Corp. in September, 2023 for $1,020,666.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AG059499-04A1 | Phase II | 1,020,666 | September 30, 2023 | |||||||
A SBIR Phase II contract was awarded to BridgeSource Medical, Corp. in September, 2023 for $1,013,092.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44HL154960-02 | Phase II | 1,013,092 | September 1, 2023 |
